A Clinical Trial to Evaluate the Safety and Efficacy in Subjects With Chronic Cough
Public ClinicalTrials.gov record NCT05392192. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Two-Period Crossover, Phase 2 Clinical Trial to Evaluate the Safety, Tolerability, and Efficacy of ADX-629 Administered Orally to Subjects With Chronic Cough
Study identification
- NCT ID
- NCT05392192
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Aldeyra Therapeutics, Inc.
- Industry
- Enrollment
- 51 participants
Conditions and interventions
Conditions
Interventions
- ADX-629 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 6, 2022
- Primary completion
- Apr 12, 2023
- Completion
- Apr 12, 2023
- Last update posted
- Feb 27, 2025
2022 – 2023
United States locations
- U.S. sites
- 14
- U.S. states
- 11
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Allergy Associates Medical Group, Inc. | San Diego | California | 92108 | — |
| Allergy & Asthma Associates of Santa Clara Valley Research Center | San Jose | California | 95117 | — |
| Cano Research - Hollywood | Hollywood | Florida | 33024 | — |
| Advanced Pulmonary Research Institute | Loxahatchee Groves | Florida | 33470 | — |
| Florida Pulmonary Research Institute LLC | Winter Park | Florida | 32789 | — |
| ClinCept | Columbus | Georgia | 31904 | — |
| Mayo Clinic Pulmonary Clinic Research Unit | Rochester | Minnesota | 55901 | — |
| Mount Sinai | New York | New York | 10003 | — |
| Charlotte Lung & Health/American Health Research | Charlotte | North Carolina | 28277 | — |
| Bernstein Clinical Research Center, LLC | Cincinnati | Ohio | 45236 | — |
| Vital Prospects Clinical Research | Tulsa | Oklahoma | 74136 | — |
| Northwest Research Center | Portland | Oregon | 97202 | — |
| Clinical Research of Rock Hill | Rock Hill | South Carolina | 29732 | — |
| Pharmaceutical Research and Consulting Inc. | Dallas | Texas | 72531 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05392192, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 27, 2025 · Synced Jun 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05392192 live on ClinicalTrials.gov.